Remove 2026 Remove Disease Remove Pharma Companies Remove Therapies
article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. Cell and gene therapies. In 2021, levels of investment hit an all-time high at $22.7

Drugs 130
article thumbnail

The building blocks of AI success stories

Drug Discovery World

He says: “Then, maybe in 2025/2026, we’re ready to apply vast and dramatic AI models, because then we’ll have it.” Ever since the 2020 Nobel Prize was awarded, it’s just gone bonkers: new start-ups, new cell therapy techniques, new assays… All the best attended sessions at SLAS 2023 were CRISPR-based.

article thumbnail

Fibrosis research: Advances and challenges 

Drug Discovery World

PW: The big challenge with fibrotic diseases is that they evolve slowly and are diagnosed late in the disease process. Only a few drugs have received approval for fibrotic diseases like IPF (idiopathic pulmonary fibrosis). Patients experience severe side effects with current medications leading them to discontinue therapy.